Werkgroep Cardiologische centra Nederland

DELIVER (Recruiting)

An International, Double-blind, Randomised Placebo-Controlled Phase III Study to Evaluate the Effect of Dapagliflozin on Morbidity and Mortality in Patients with HFpEF
Medicine
dapagliflozin
Population
Heart failure
Phase
III
Starting year
2017